MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

White House directs HHS and CDC to align childhood vaccine recommendations with “best practices from peer, developed countries”

In a Dec. 5 memo, President Donald Trump directed the HHS secretary and the CDC director to “align the U.S. core childhood vaccine recommendations with best practices from peer, developed countries.”

HHS issues AI strategy for internal agency operations

HHS has issued its AI strategy—“the first step” in making a “whole-of-department transformation” towards the use of artificial intelligence in public health, health care delivery, biomedical research, human services, and agency operations.

Curebound announces eight grants totaling $2M to address emerging areas of cancer research

Curebound has announced eight grants for a total of $2 million in funding. The funding is made available through two new Curebound programs: Catalyst Grants, which support projects within early-stage life science companies that are seeking to take innovative discoveries to commercially approved products, and Equity Grants, which focus on overcoming disparities in cancer research and treatment in underserved populations.

December 12, 2025

Vol.51 No.45

In Brief

Paradigm Health acquires Flatiron Health’s clinical research business

Paradigm Health and Flatiron Health announced that Paradigm Health will acquire Flatiron’s Clinical Research Business, which has built a tech-enabled U.S. oncology research network.

December 05, 2025

Vol.51 No.44

Clinical Roundup

Patients in Nepal experience substantial delays when accessing cancer care, study finds

Substantial delays are taking place across the cancer care pathway in Nepal, with many patients waiting months between first symptoms and treatment, according to an article by the International Agency for Research on Cancer and partners.

December 05, 2025

Vol.51 No.44

Drugs & Targets

Université Paris-Saclay, Owkin partner to use AI co-pilot for biology research

Xavier Apolinarski (left), vice president of innovation at Université Paris-Saclay, and Eric Durand (right), chief research and technology officer at Owkin at the signing of the deal between Université Paris-Saclay and Owkin.Université Paris-Saclay and Owkin announce the signing of a memorandum of understanding to explore the potential of K Pro Free—Owkin’s AI co-pilot for biology—for use by Université Paris-Saclay.

December 05, 2025

Vol.51 No.44

MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

YOU MAY BE INTERESTED IN

White House directs HHS and CDC to align childhood vaccine recommendations with “best practices from peer, developed countries”

HHS issues AI strategy for internal agency operations

Curebound announces eight grants totaling $2M to address emerging areas of cancer research

Paradigm Health acquires Flatiron Health’s clinical research business

Patients in Nepal experience substantial delays when accessing cancer care, study finds

Université Paris-Saclay, Owkin partner to use AI co-pilot for biology research

Renew today!

Subscriber content

Never miss an issue!

Login